01/03/2025
4:50 PM | Avenue Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
3:21 PM | Avenue Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2024
3:30 PM | Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
3:05 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:22 PM | ARMISTICE CAPITAL, LLC (Filed by)
Avenue Therapeutics (Subject)
| Form SC 13G | |
11/07/2024
6:12 PM | Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:18 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:53 PM | Avenue Therapeutics (Issuer)
Charles Faith L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:53 PM | Avenue Therapeutics (Issuer)
Jin David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:54 PM | Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:55 PM | Avenue Therapeutics (Issuer)
MacLean Alexandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/25/2024
3:55 PM | Avenue Therapeutics (Issuer)
Oltmans Curtis Gale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:57 PM | Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:59 PM | Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:16 PM | Avenue Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2024
3:52 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
7:30 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:01 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2024
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
03/29/2024
1:41 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:15 AM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:31 PM | Avenue Therapeutics (Filer)
| Form PRE 14C | |
02/23/2024
3:17 PM | Avenue Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
01/29/2024
7:00 AM | Avenue Therapeutics (Filer)
| Form DEF 14C | |
